Choosing dopamine agonists in Parkinson's disease.

@article{Tan2001ChoosingDA,
  title={Choosing dopamine agonists in Parkinson's disease.},
  author={Eng-King Tan and J Sladjana Jankovic},
  journal={Clinical neuropharmacology},
  year={2001},
  volume={24 5},
  pages={
          247-53
        }
}
Dopamine agonists (DAs) have been shown to be effective as monotherapy in early stages of Parkinson's disease (PD) and as an adjunctive treatment to levodopa in advanced PD. Since bromocriptine, an ergot compound, was introduced as the first commercially available DA more than 25 years ago, additional DAs have become available for clinical use. There is a remarkable paucity of data, however, that would guide clinicians in their decision process to select the most appropriate DAs. We discuss the… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Similar Papers

Loading similar papers…